New York Times
BREAKING NEWS |
Pfizer completed its coronavirus vaccine trial. It says the shots are 95 percent effective, have no serious side effects and work for older people. |
Wednesday, November 18, 2020 6:48 AM EST |
The drug maker Pfizer offered on Wednesday the first set of complete results from a late-stage vaccine trial as Covid-19 cases skyrocket around the globe. The data showed that the vaccine prevented mild and severe forms of Covid-19, the company said. And it was 94 percent effective in older adults, who are more vulnerable to developing severe Covid-19 and who do not respond strongly to some types of vaccines. |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.